David Andrew Morrow, M.D.
Co-Author
This page shows the publications co-authored by David Morrow and Brian Bergmark.
Connection Strength
3.303
-
Cardiac troponin elevation after elective PCI: adding infarct to major injury. Eur Heart J. 2021 01 21; 42(4):335-338.
Score: 0.941
-
Beyond the ISCHEMIA Trial: Revascularization for Stable Ischemic Heart Disease in Patients With High-Risk Coronary Anatomical Features. J Am Heart Assoc. 2021 01 05; 10(1):e019974.
Score: 0.935
-
Baseline adiponectin concentration and clinical outcomes among patients with diabetes and recent acute coronary syndrome in the EXAMINE trial. Diabetes Obes Metab. 2017 07; 19(7):962-969.
Score: 0.721
-
Klotho, fibroblast growth factor-23, and the renin-angiotensin system - an analysis from the PEACE trial. Eur J Heart Fail. 2019 04; 21(4):462-470.
Score: 0.206
-
Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial. JAMA Cardiol. 2018 06 01; 3(6):473-480.
Score: 0.196
-
Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease. Diabetes Care. 2018 03; 41(3):577-585.
Score: 0.189
-
Recombinant human Lecithin-Cholesterol acyltransferase in patients with atherosclerosis: Phase 2a primary results and phase 2b design. Eur Heart J Cardiovasc Pharmacother. 2021 Jan 25.
Score: 0.059
-
Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome. J Am Coll Cardiol. 2020 03 17; 75(10):1095-1106.
Score: 0.055
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.